Affluent Medical

Capital/Financing Update • Jan 29, 2024

Half-year liquidity contract statement for Affluent Medical

Public limited company with a capital of € 30 896 652

Registered office: 320, avenue Archimède Les Pléiades III - Bâtiment B 13100 Aix-en-Provence - France 837 722 560 R.C.S. on the Aix-en-Provence Trade and Companies Register

Under the liquidity contract entered into between Affluent Medical and Kepler Cheuvreux, the following resources appeared on the liquidity account on December 31st, 2023:

• 121,275 shares
• € 52,773.48
• Number of executions on buy side on semester: 341
• Number of executions on sell side on semester: 289
• Traded volume on buy side on semester: 54,718 shares for € 68,987.34
• Traded volume on sell side on semester: 57,675 shares for € 81,730.92

As a reminder:

• the following resources appeared on the last half year statement on 30 June 2023 on the liquidity account:
• 124,232 shares
• € 39,485.10
• Number of executions on buy side on semester: 245
• Number of executions on sell side on semester: 129
• Traded volume on buy side on semester: 35,717 shares for € 50,544.84
• Traded volume on sell side on semester: 21,629 shares for € 32,173.80
• the following resources appeared on the liquidity account when the activity started:
• 0 shares

€ 400,000.00

The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd, 2021, renewing the implementation of liquidity contracts for shares as an accepted market practice.

Buy Side Number of Number of Traded volume in executions shares EUR Total 341 54,718 68,987.34 03/07/2023 2 200 244.00	Number of executions 289
	-
04/07/2023 3 329 391.51	-
05/07/2023 5 472 542.8	1
06/07/2023 3 401 453.13	3
07/07/2023 1 100 112.00	2
10/07/2023 1 1 1.12	3
11/07/2023 5 583 647.13	5
12/07/2023 3 219 245.28	3
13/07/2023 2 400 452.00	1
14/07/2023 1 1 1.15	2
18/07/2023 4 601 673.12	1
19/07/2023 2 200 228.00	-
20/07/2023 3 200 224.00	2
25/07/2023 2 400 440,00	-
26/07/2023 3 401 453.13 2
27/07/2023 1 72 80.64 -
28/07/2023 4 129 144.48 1
31/07/2023 1 9 10.08 1
01/08/2023 5 592 663.04 1
02/08/2023 1 17 19.38 -
03/08/2023 5 343 387.59 1
04/08/2023 3 200 228.00 -
07/08/2023 1 2 2.26 -
08/08/2023 1 172 194.36 -
09/08/2023 6 250 285.00 -
10/08/2023 10 618 685.98 4
15/08/2023 - - - 1
16/08/2023 1 40 44.4 -
17/08/2023 1 1 1.11 1
18/08/2023 1 1 1.11 3
21/08/2023 3 300 330.00 -
22/08/2023 4 200 220.00 -
23/08/2023 9 1 700 1,819.00 -
24/08/2023 5 501 531.06 1
25/08/2023 2 21 22.68 1
28/08/2023 3 180 194.4 -
29/08/2023 3 200 212,00 1
31/08/2023 4 309 330.63 1
01/09/2023 5 492 521.52 1
04/09/2023 - - - 1

Number of executions	Number of shares	Traded volume in EUR

	Buy Side		Sell Side
	Number of executions	Number of shares	Traded volume in EUR	Number of executions	Number of shares	Traded volume in EUR
Total	341	54,718	68,987.34	289	57,675	81,730.92
05/09/2023	2	99	102.96	2	71	75.26
06/09/2023	1	1	1.05	2	201	213.06
08/09/2023	3	303	318.15	1	1	1.07
11/09/2023	1	1	1.05	1	1	1.05
12/09/2023	1	1	1.05	1	1	1.05
13/09/2023	-	-	-	3	200	212.00
14/09/2023	-	-	-	75	22 501	32,626.45
15/09/2023	27	9 373	13,122.2	-	-	-
18/09/2023	17	3 246	4,252.26	2	200	280.00
19/09/2023	14	2 252	2,679.88	1	1	1.25
20/09/2023	9	1 100	1,287,00	1	1	1.22
21/09/2023	1	430	490.2	-	-	-
22/09/2023	5	1 201	1,345.12	3	201	233.16
25/09/2023	2	201	221.1	1	1	1.11
27/09/2023	13	4 201	4,285.02	2	5	5.6
28/09/2023	6	1 126	1,092.22	6	1 500	1,560.00
29/09/2023	5	800	776.00	1	1	1.04
02/10/2023	-	-	-	1	500	510.00
03/10/2023	3	112	112.00	4	1 500	1,590.00
04/10/2023	9	1 893	1,949.79	1	1	1.04
05/10/2023	1	1	1.04	2	500	520.00
06/10/2023	1	1	1.05	3	4	4.24
09/10/2023	6	844	860.88	1	1	1.05
10/10/2023	1	1	1.01	1	1	1.01
11/10/2023	3	358	358.00	3	119	121.38
12/10/2023	2	501	501.00	1	1	1.01
13/10/2023	1	1	1.00	2	383	390.66
16/10/2023	-	-	-	1	1	1.04
17/10/2023	1	1	1.03	4	1 000	1,030.00
18/10/2023	1	1	1.03	2	501	516.03
19/10/2023	-	-	-	1	252	264.6
20/10/2023	-	-	-	3	220	233.2
23/10/2023	-	-	-	2	401	425.06
24/10/2023	1	1	1.06	2	25	26.5
25/10/2023	2	500	530.00	-	-	-
26/10/2023	1	1	1.07	6	1 201	1,297.08
27/10/2023	3	200	220.00	10	1 482	1,748.76
30/10/2023	-	-	-	1	113	141.25
31/10/2023	2	500	600.00	2	121	150.04
01/11/2023	2	334	414.16	5	480	595.2

Number of executions	Number of shares	Traded volume in EUR

	Buy Side			Sell Side
	Number of executions	Number of shares	Traded volume in EUR	Number of executions	Number of shares	Traded volume in EUR
Total	341	54,718	68,987.34	289	57,675	81,730.92
02/11/2023	-	-	-	3	200	254.00
03/11/2023	5	200	252.00	-	-	-
06/11/2023	1	1	1.27	5	96	121.92
07/11/2023	3	408	510.00	2	106	134.62
08/11/2023	3	94	117.5	2	81	102.87
09/11/2023	2	201	251.25	2	121	153.67
10/11/2023	-	-	-	1	200	256.00
14/11/2023	2	200	254.00	-	-	-
15/11/2023	1	1	1.26	3	119	151.13
16/11/2023	-	-	-	1	82	104.14
17/11/2023	4	500	630.00	-	-	-
21/11/2023	1	20	25.00	1	180	228.6
22/11/2023	2	51	63.75	1	1	1.26
23/11/2023	6	159	198.75	-	-	-
24/11/2023	2	238	295.12	6	820	1,057.8
27/11/2023	-	-	-	1	1	1.3
28/11/2023	-	-	-	1	499	648.7
29/11/2023	-	-	-	2	500	655.00
30/11/2023	9	2 533	3,242.24	1	1	1.31
01/12/2023	-	-	-	2	700	889.00
04/12/2023	1	3	3.81	1	300	384.00
05/12/2023	1	500	640.00	4	1 500	1,950.00
06/12/2023	3	998	1,277.44	1	1	1.28
07/12/2023	3	868	1,093.68	-	-	-
08/12/2023	4	1 100	1,375.00	-	-	-
11/12/2023	2	500	620.00	-	-	-
12/12/2023	1	500	615.00	-	-	-
13/12/2023	1	1	1.24	2	501	621.24
14/12/2023	-	-	-	4	601	751.25
15/12/2023	-	-	-	5	2 399	3,070.72
18/12/2023	-	-	-	1	500	655.00
19/12/2023	-	-	-	10	3 000	4,050.00
20/12/2023	-	-	-	1	259	388.5
21/12/2023	-	-	-	4	1 500	2,655.00
22/12/2023	-	-	-	7	4 005	8,370.45
27/12/2023	8	2 469	5,036.76	3	1 177	2,577.63
28/12/2023	10	2 731	4,915.8	3	1 300	2,405.00
29/12/2023	-	-	-	5	1 000	1,800.00

Number of executions	Number of shares	Traded volume in EUR

Affluent Medical

Affluent Medical is a French MedTech company, founded by Truffle Capital, with the ambition to become a global leader in the treatment of structural heart diseases, which are the world's leading cause of mortality, and urinary incontinence, which currently affects one in four adults.

Affluent Medical develops next-generation, mini-invasive, innovative, adjustable, and biomimetic implants to restore critical physiological functions. The product candidates developed by the Company are currently in preclinical and clinical studies.

Kalios, the first mitral adjustable annuloplasty ring, should be the first Affluent Medical device to be marketed.

Subject to raising the necessary funds to finance its strategy and to positive results from ongoing clinical studies, the Company's ambition is to gradually commercialize its products from the end of 2025/early 2026.

For more information, visit www.affluentmedical.com

Contacts:

AFFLUENT MEDICAL

Sébastien LADET Chief Executive Officer investor@affluentmedical.com

PRIMATICE Media relations France Thomas ROBOREL de CLIMENS +33 (0)6 78 12 97 95 thomasdeclimens@primatice.com

SEITOSEI.ACTIFIN Financial communications / press relations Ghislaine GASPARETTO / Jennifer JULLIA +33 (0)6 21 10 49 24 / +33 (0)1 56 88 11 19 ghislaine.gasparetto@seitosei-actifin.com / jennifer.jullia@seitosei-actifin.com

MC SERVICES AG Media relations Europe Caroline BERGMANN / Kirsten RÜHL +49 (0)211 529252 20 / +49 (0)211 529252 16 affluent@mc-services.eu